NCT02044081View on ClinicalTrials.gov

Phase 2, Safety & Microbiology Study of C16G2 in Multiple Oral Gel &/or Mouth Rinse Doses to Healthy Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

August 31, 2014

Conditions
Dental Caries
Interventions
DRUG

C16G2 Rinse

Active rinses are 1.6 mg/mL C16G2.

DRUG

Placebo

Placebo is the vehicle without C16G2

DRUG

C16G2 Gel

Active C16G2 Gel is 3.2 mg/mL

Trial Locations (2)

59901

Plaza West II Dental Group, Kalispell

84124

Jean Brown Research, Salt Lake City

Sponsors
All Listed Sponsors
lead

Armata Pharmaceuticals, Inc.

INDUSTRY